Publication: The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction
Loading...
Program
relationships.isAuthorOf
Author
ÖZDEMİR, Ramazan
Pfister, Roman
Bergmann, Martin W.
Bartunek, Jozef
KILIÇ, TEOMAN
Lauten, Alexander
Schmeisser, Alexander
ZOGHİ, MEHDİ
Anker, Stefan
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.
Description
Source
Keywords
Keywords
Citation
Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W. , Bartunek J., KILIÇ T., Lauten A., Schmeisser A., ZOGHİ M., Anker S., et al., -The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction-, EUROINTERVENTION, cilt.15, ss.403-410, 2019